单细胞分析揭示进展性特发性肺纤维化的免疫异常
进展性和稳定性IPF患者经典单核细胞增多,进展性IPF患者调节性T细胞(Treg)增多且可能伴生存期缩短,趋化因子CCL22和CCL18在IPF中升高。
要点
- 进展性IPF患者经典单核细胞和Treg比例升高,Treg增多可能提示生存期缩短。
- IPF患者总淋巴细胞减少,进展性较稳定性IPF进一步降低。
- CCL22和CCL18在IPF中升高,提示肺-血免疫招募轴参与发病。
核心结论
- IPF外周免疫单细胞图谱显示经典单核细胞和Treg的结局预测性增加,并存在涉及CCL7和CCL18/CCL22的肺-血免疫招募轴证据。
主要发现
- 149,564个细胞分为23个亚群;经典单核细胞在进展性、稳定性和对照中分别为32.1%、25.2%和17.9%(P < 0.05)。
- 总淋巴细胞在IPF患者低于对照,进展性低于稳定性IPF(52.6% vs. 62.6%,P = 0.035)。
- Treg在进展性IPF高于稳定性IPF(占全部PBMC的1.8% vs. 1.1%,P = 0.007),但与对照无差异。
- Treg增多与生存期缩短可能相关(Kaplan-Meier分析P = 0.009;调整年龄、性别和基线FVC后P = 0.069)。
- CCL22和CCL18(CCR4和CCR8 Treg趋化受体配体)在IPF中升高。
临床怎么用
- 外周血经典单核细胞和Treg比例可能作为IPF进展和预后评估的候选生物标志物。
- CCL18/CCL22及CCL7相关趋化轴或为IPF免疫干预提供潜在靶点。
局限性
- 研究样本量有限(25例IPF和13名对照),结论需更大队列验证。
- Treg与生存关联在调整基线FVC后未达统计学显著(P = 0.069)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Changes in peripheral blood cell populations have been observed, but not detailed, at single-cell resolution in idiopathic pulmonary fibrosis (IPF). Objectives: We sought to provide an atlas of the changes in the peripheral immune system in stable and progressive IPF. Methods: Peripheral blood mononuclear cells (PBMCs) from patients with IPF and control subjects were profiled using 10× chromium 5' single-cell RNA sequencing. Flow cytometry was used for validation. Protein concentrations of regulatory T cells (Tregs) and monocyte chemoattractants were measured in plasma and lung homogenates from patients with IPF and control subjects. Measurements and Main Results: Thirty-eight PBMC samples from 25 patients with IPF and 13 matched control subjects yielded 149,564 cells that segregated into 23 subpopulations. Classical monocytes were increased in patients with progressive and stable IPF compared with control subjects (32.1%, 25.2%, and 17.9%, respectively; P < 0.05). Total lymphocytes were decreased in patients with IPF versus control subjects and in progressive versus stable IPF (52.6% vs. 62.6%, P = 0.035). Tregs were increased in progressive versus stable IPF (1.8% vs. 1.1% of all PBMCs, P = 0.007), although not different than controls, and may be associated with decreased survival (P = 0.009 in Kaplan-Meier analysis; and P = 0.069 after adjusting for age, sex, and baseline FVC). Flow cytometry analysis confirmed this finding in an independent cohort of patients with IPF. The fraction of Tregs out of all T cells was also increased in two cohorts of lung single-cell RNA sequencing. CCL22 and CCL18, ligands for CCR4 and CCR8 Treg chemotaxis receptors, were increased in IPF. Conclusions: The single-cell atlas of the peripheral immune system in IPF reveals an outcome-predictive increase in classical monocytes and Tregs, as well as evidence for a lung-blood immune recruitment axis involving CCL7 (for classical monocytes) and CCL18/CCL22 (for Tregs).
引用
- Unterman A, Zhao AY, Neumark N, et al. Single-Cell Profiling Reveals Immune Aberrations in Progressive Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2024. PMID: 38717443. doi:10.1164/rccm.202306-0979OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。